Clinic
Aizer Health , INC.
Aizer Health , INC. was paid $117.87M by Medicaid between Jan 2018 and Dec 2024, across 200 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoAIZER HEALTH , INC.
MONROE, NY 10950
MONROE, NY 10950
33aNPI1063480218assigned 03/14/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$117.87M
24GClaims2,038,020
24DCodes billed200
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in New York
Rank by total paid#1 of 118
Median peer was paid$372K
This provider vs. median317×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 243,290 | $15.29M | |
| 2019 | 276,768 | $15.76M | |
| 2020 | 269,263 | $14.56M | |
| 2021 | 311,184 | $16.93M | |
| 2022 | 221,022 | $13.00M | |
| 2023 | 396,307 | $23.71M | |
| 2024incomplete | 320,186 | $18.61M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 504,325 | 276,738 | $35.51M |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 7.5% | 2,738 | 2,737 | $8.87M |
| 81002 | 4.6% | 106,034 | 63,777 | $5.42M | |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | 3.9% | 79,219 | 58,102 | $4.54M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.8% | 42,098 | 26,308 | $4.52M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.6% | 40,707 | 9,937 | $3.08M |
| D2150 | Silver amalgam - two surfaces, primary or permanent | 2.6% | 29,425 | 16,787 | $3.01M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.4% | 38,352 | 8,325 | $2.85M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.4% | 28,419 | 9,838 | $2.81M |
| D1110 | Prophylaxis - adult | 2.3% | 39,319 | 33,317 | $2.66M |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 2.0% | 23,461 | 13,960 | $2.38M |
| D8670 | Periodic orthodontic treatment visit | 1.8% | 9,552 | 9,339 | $2.07M |
188 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | 1.5% | 18,361 | $1.75M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.5% | 16,263 | $1.74M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 22,685 | $1.61M |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.3% | 19,264 | $1.56M |
| D1120 | Dental cleaning, child | 1.3% | 28,438 | $1.55M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.3% | 25,478 | $1.54M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 20,292 | $1.31M |
| D0220 | Intraoral - periapical first radiographic image | 1.1% | 59,217 | $1.31M |
| D0274 | Bitewings - four radiographic images | 1.1% | 37,848 | $1.24M |
| 99051 | <1% | 50,227 | $1.16M | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 13,314 | $1.11M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 18,041 | $1.10M |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 48,321 | $999K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 11,349 | $917K |
| D0140 | Limited oral evaluation - problem focused | <1% | 15,210 | $867K |
| 36415 | Collection of venous blood by venipuncture | <1% | 71,191 | $860K |
| 76801 | <1% | 5,426 | $755K | |
| D2140 | <1% | 8,799 | $721K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 3,088 | $716K |
| W0003 | <1% | 6,354 | $695K | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 31,619 | $635K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 7,600 | $609K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 5,734 | $580K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 3,806 | $572K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 8,037 | $551K |
| 76818 | <1% | 4,246 | $511K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 5,864 | $496K |
| 17110 | <1% | 4,072 | $431K | |
| 11056 | <1% | 8,360 | $418K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 21,904 | $410K |
| 76830 | Ultrasound, transvaginal | <1% | 4,633 | $390K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 4,865 | $358K |
| D2160 | <1% | 3,418 | $358K | |
| 11721 | <1% | 9,013 | $344K | |
| D0270 | <1% | 12,124 | $341K | |
| D9110 | <1% | 5,415 | $320K | |
| 99381 | <1% | 3,325 | $316K | |
| 87428 | <1% | 9,475 | $312K | |
| 99460 | <1% | 3,229 | $306K | |
| 11730 | <1% | 2,821 | $299K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 5,053 | $284K |
| D1206 | Topical application of fluoride varnish | <1% | 8,075 | $279K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 2,711 | $276K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,886 | $273K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,219 | $269K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 29,129 | $266K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 3,579 | $264K |
| 92522 | <1% | 2,871 | $255K | |
| 92065 | <1% | 4,024 | $252K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 3,298 | $252K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 2,479 | $250K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,710 | $247K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 15,163 | $226K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,939 | $214K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 120,433 | $194K |
| D1351 | Sealant - per tooth | <1% | 2,604 | $193K |
| D8080 | Comprehensive orthodontic treatment of the adolescent dentition | <1% | 201 | $192K |
| 76820 | <1% | 4,821 | $186K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,338 | $183K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,235 | $156K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 2,343 | $150K |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 1,438 | $148K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,113 | $130K |
| 92523 | <1% | 951 | $125K | |
| 11720 | <1% | 3,811 | $121K | |
| 99442 | <1% | 1,726 | $115K | |
| 90837 | Psychotherapy session, about an hour | <1% | 876 | $115K |
| D2331 | <1% | 1,135 | $113K | |
| D0340 | <1% | 2,346 | $113K | |
| 59025 | Fetal non-stress test | <1% | 2,075 | $112K |
| D0330 | Panoramic radiographic image | <1% | 3,388 | $110K |
| D2740 | Crown - porcelain/ceramic | <1% | 495 | $107K |
| D1999 | <1% | 2,182 | $104K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 637 | $99K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 975 | $93K |
| D9995 | <1% | 1,486 | $83K | |
| 69210 | <1% | 1,250 | $77K | |
| 97161 | <1% | 1,027 | $74K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 217 | $71K |
| D8660 | <1% | 2,508 | $70K | |
| 92524 | <1% | 750 | $70K | |
| 87430 | <1% | 20,797 | $62K | |
| 11055 | <1% | 1,536 | $58K | |
| 92551 | <1% | 17,591 | $56K | |
| 99441 | <1% | 837 | $52K | |
| D0350 | <1% | 4,444 | $51K | |
| D2332 | <1% | 411 | $45K | |
| 90686 | <1% | 6,956 | $45K | |
| 99349 | <1% | 547 | $45K | |
| 81025 | <1% | 8,222 | $44K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,631 | $40K |
| D2751 | Crown - porcelain fused to predominantly base metal | <1% | 171 | $40K |
| D9310 | <1% | 516 | $39K | |
| D8680 | <1% | 304 | $38K | |
| 0502F | <1% | 330 | $34K | |
| 11057 | <1% | 401 | $32K | |
| 11102 | <1% | 312 | $29K | |
| 92250 | <1% | 394 | $26K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 233 | $26K |
| 76998 | <1% | 252 | $25K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 3,342 | $25K |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 28 | $21K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,117 | $21K |
| S0620 | Routine ophthalmological examination including refraction; new patient | <1% | 152 | $18K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,898 | $15K |
| 99385 | <1% | 174 | $15K | |
| 97165 | <1% | 174 | $14K | |
| 59426 | <1% | 13 | $14K | |
| 99050 | <1% | 543 | $13K | |
| S0621 | Routine ophthalmological examination including refraction; established patient | <1% | 110 | $13K |
| 92015 | Determination of refractive state | <1% | 19,084 | $12K |
| 36416 | <1% | 15,756 | $12K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 965 | $10K |
| 31579 | <1% | 62 | $10K | |
| G0467 | Community health center visit, returning patient | <1% | 202 | $10K |
| 92521 | <1% | 91 | $9K | |
| D4341 | <1% | 78 | $9K | |
| 76813 | <1% | 59 | $8K | |
| 87807 | <1% | 1,091 | $7K | |
| D0272 | Bitewings - two radiographic images | <1% | 263 | $7K |
| 85018 | <1% | 8,931 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 723 | $7K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 46 | $7K |
| 90715 | <1% | 715 | $6K | |
| 97116 | <1% | 91 | $6K | |
| 99443 | <1% | 67 | $5K | |
| 92002 | <1% | 62 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 180 | $5K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 107 | $5K |
| 99459 | <1% | 264 | $5K | |
| 12011 | <1% | 37 | $4K | |
| 0012A | <1% | 126 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,662 | $4K |
| 0031A | <1% | 84 | $3K | |
| 0011A | <1% | 116 | $3K | |
| 58300 | <1% | 29 | $3K | |
| 93000 | <1% | 164 | $2K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 47 | $2K |
| 11100 | <1% | 29 | $2K | |
| 58301 | <1% | 26 | $2K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 20 | $2K |
| 90697 | <1% | 2,590 | $2K | |
| 86756 | <1% | 549 | $2K | |
| 90461 | <1% | 15,583 | $1K | |
| 73630 | <1% | 46 | $1K | |
| 0503F | <1% | 14 | $1K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 34 | $1K |
| 99205 | Prolong outpt/office vis | <1% | 13 | $1K |
| 90281 | <1% | 13 | $1K | |
| 90836 | <1% | 12 | $1K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 14 | $920.05 |
| 90656 | <1% | 199 | $887.53 | |
| 90677 | <1% | 1,963 | $758.71 | |
| 73610 | <1% | 12 | $402.96 | |
| 87088 | <1% | 167 | $346.02 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 34 | $304.21 |
| 85048 | <1% | 595 | $264.57 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 19 | $212.50 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 59 | $211.13 |
| 90716 | <1% | 1,016 | $131.00 | |
| 90707 | <1% | 2,024 | $129.60 | |
| 90723 | <1% | 4,225 | $100.00 | |
| 82271 | <1% | 327 | $78.66 | |
| 86580 | <1% | 28 | $75.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12 | $60.00 |
| 94760 | <1% | 346 | $43.17 | |
| 90647 | <1% | 2,341 | $25.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 544 | $19.31 |
| 83986 | <1% | 314 | $9.83 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 12 | $4.34 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 15 | $0.78 |
| 91301 | <1% | 277 | $0.01 | |
| 90670 | 0% | 5,079 | $0.00 | |
| 90734 | 0% | 933 | $0.00 | |
| 90710 | 0% | 1,461 | $0.00 | |
| 90700 | 0% | 1,274 | $0.00 | |
| 97803 | 0% | 1,358 | $0.00 | |
| 90380 | 0% | 73 | $0.00 | |
| 90655 | 0% | 17 | $0.00 | |
| 90685 | 0% | 38 | $0.00 | |
| 90713 | 0% | 13 | $0.00 | |
| 90744 | 0% | 123 | $0.00 | |
| 97802 | 0% | 156 | $0.00 | |
| 90696 | 0% | 1,071 | $0.00 | |
| D8999 | 0% | 460 | $0.00 | |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 14 | $0.00 |
| 99000 | 0% | 26 | $0.00 | |
| 91303 | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMITTELMAN, JOEL (EXECUTIVE DIRECTOR)